ARTICLE | Management Tracks
New CSO at Everest; plus Wugen, Evelo, Inflammatix, ImCheck and more
April 15, 2021 11:48 PM UTC
Cross-border licensing company Everest Medicines Ltd. (HKEX:1952) hired Jennifer Yang as CSO. Yang was previously VP and head of China for the lung cancer initiative at Johnson & Johnson (NYSE:JNJ).
Allogeneic cell therapy developer Wugen Inc. hired Daniel Kemp as CEO. Kemp joins from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK), where he was VP and head of cell therapies business development and operations. Kemp succeeds founding CEO John McKearn, who will continue to serve as chairman. ...